These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 19483704)

  • 41. Essential AIDS medications in India.
    Thomas J
    Issues Med Ethics; 2000; 8(2):62. PubMed ID: 16323350
    [No Abstract]   [Full Text] [Related]  

  • 42. Trade secret protection in the pharma industry.
    Armstrong M
    Pharm Pat Anal; 2016 Sep; 5(5):285-8. PubMed ID: 27572950
    [No Abstract]   [Full Text] [Related]  

  • 43. FDA chief attacks Canada's drug price controls.
    Webster P
    Lancet; 2003 Nov; 362(9398):1816. PubMed ID: 14661624
    [No Abstract]   [Full Text] [Related]  

  • 44. Impact of India's new patents law 2005: a physician's perspective.
    Lele RD
    J Assoc Physicians India; 2005 Aug; 53():671-5. PubMed ID: 16398073
    [No Abstract]   [Full Text] [Related]  

  • 45. Legitimate patent extension or patent system abuse?
    Atkinson JD; Moodie RS
    Pharm Pat Anal; 2013 May; 2(3):317-24. PubMed ID: 24237059
    [TBL] [Abstract][Full Text] [Related]  

  • 46. What's fueling the biotech engine--2010 to 2011.
    Aggarwal S
    Nat Biotechnol; 2011 Dec; 29(12):1083-9. PubMed ID: 22158359
    [No Abstract]   [Full Text] [Related]  

  • 47. Redesigner drugs.
    Dove A
    Nat Biotechnol; 2004 Aug; 22(8):953-7. PubMed ID: 15286643
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Medication prices in Germany--how are they determined?].
    Bruhn C
    Dtsch Med Wochenschr; 2010 Oct; 135(39):p34. PubMed ID: 20922657
    [No Abstract]   [Full Text] [Related]  

  • 49. Pharmaceutical forecasting: throwing darts?
    Cha M; Rifai B; Sarraf P
    Nat Rev Drug Discov; 2013 Oct; 12(10):737-8. PubMed ID: 24080692
    [No Abstract]   [Full Text] [Related]  

  • 50. Mergers in Japan help firms retain own products.
    Fuyuno I
    Nat Rev Drug Discov; 2005 May; 4(5):358. PubMed ID: 15902766
    [No Abstract]   [Full Text] [Related]  

  • 51. Reinventing an industry.
    Mandavilli A
    Nature; 2007 Jan; 445(7124):138-9. PubMed ID: 17215817
    [No Abstract]   [Full Text] [Related]  

  • 52. Big interest in heavy drugs.
    Sanderson K
    Nature; 2009 Mar; 458(7236):269. PubMed ID: 19295573
    [No Abstract]   [Full Text] [Related]  

  • 53. Market watch: Specialty pharmaceuticals to provide majority of sales by 2012.
    Goodman M
    Nat Rev Drug Discov; 2009 Mar; 8(3):184. PubMed ID: 19247297
    [No Abstract]   [Full Text] [Related]  

  • 54. Biomanufacturing, from bust to boom...to bubble?
    Thiel KA
    Nat Biotechnol; 2004 Nov; 22(11):1365-72. PubMed ID: 15529157
    [No Abstract]   [Full Text] [Related]  

  • 55. Novelty: new products and processes.
    French H
    Nat Rev Drug Discov; 2004 Jun; 3(6):469. PubMed ID: 15214329
    [No Abstract]   [Full Text] [Related]  

  • 56. Protection of commercial opportunity.
    Wyllie MG
    BJU Int; 2012 Feb; 109(3):E8-9. PubMed ID: 22243668
    [No Abstract]   [Full Text] [Related]  

  • 57. Drug Pricing Regulation Pushed From Many Sides.
    Kirkner RM
    Manag Care; 2016 Jan; 25(1):14-5. PubMed ID: 26882623
    [No Abstract]   [Full Text] [Related]  

  • 58. Auctioning the cure.
    Willyard C
    Nat Med; 2011 May; 17(5):528-30. PubMed ID: 21546960
    [No Abstract]   [Full Text] [Related]  

  • 59. Patent watch: Drug patenting in India: looking back and looking forward.
    Sampat BN; Shadlen KC
    Nat Rev Drug Discov; 2015 Aug; 14(8):519-20. PubMed ID: 26184492
    [No Abstract]   [Full Text] [Related]  

  • 60. The 340B Drug Pricing Program: an opportunity for savings, if covered entities such as disproportionate share hospitals and federally qualified health centers know how to interpret the regulations.
    Werling K; Abraham S; Strelec J
    Health Care Law Mon; 2007 Aug; ():3-12. PubMed ID: 17955590
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.